The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
Australia’s TGA Launches Web-based ADR Reporting
Posted 25 September 2014 | By
This content is provided by RegLink News, publishers of e-weekly global regulatory news. RegLink offers a 30-day free trial and 15% discount on Global Update subscriptions to RAPS members.
Australia’s Therapeutic Goods Administration (TGA) has launched a web-based medicines and vaccine related adverse event (adverse drug reaction, or ADR) reporting system for the use of consumers.
The new web-based reporting service is one of a range of TGA initiatives targeting consumers which include:
According to published research, about 90-95% of medicines-related adverse events globally are not reported to regulatory authorities, in large part because there is a low awareness among consumers of available ADR reporting systems. In 2013, only about 3% of ADR reports received by the TGA came from consumers, compared with 55% from pharmaceutical companies, 17% from state and territory health departments, 10% from hospitals and hospital pharmacists and the remainder from community pharmacists and general practitioners.